Eflapegrastim
Eflapegrastim Uses, Dosage, Side Effects, Food Interaction and all others data.
Eflapegrastim is under investigation in clinical trial NCT02953340 (Trial of SPI-2012 Versus Pegfilgrastim in the Management of Chemotherapy Induced Neutropenia in Early- Stage BReast Cancer Patients Receiving Docetaxel and Cyclophosphamide (RECOVER)).
Trade Name | Eflapegrastim |
Generic | Eflapegrastim |
Eflapegrastim Other Names | Eflapegrastim |
Type | |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Eflapegrastim